Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Guided Therapeutics Inc.

BioPhotonics
Feb 2009
Guided Therapeutics Inc. of Norcross, Ga., has submitted the preclinical module of its Premarket Approval application to the FDA for its LightTouch noninvasive cervical cancer detection device. The system analyzes reflected light wavelengths to detect biochemical and morphological changes at the cellular level, thereby locating cervical cancers. The clinical and manufacturing modules should be submitted this year.

BiophotonicsGuided Therapeutics Inc.industrialNews & Featurespreclinical module

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.